San Francisco Bay Area biotech stories.
Thursday, September 6, 2012
Astex, U.K. groups form blood cancer research pact
Astex Pharmaceuticals Inc. inked a research collaboration with Cancer Research Technology Ltd. and the Institute of Cancer Research in London to discover and develop drug candidates for blood cancer caused by epigenetics.
Dublin-based Astex (NASDAQ: ASTX) did not disclose the value of the deal or say how long the collaboration would last.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)